Dr. Molitoris is a radiation oncologist. At the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, he strives to provide excellent patient care through a team-based approach. He also strives to help advance the field of radiation oncology through the implementation of newer treatment technologies, such as proton therapy, brachytherapy and hyperthermia therapy, and translational research.
Among Dr. Molitoris’ main clinical and research interests are genitourinary (prostate, bladder, kidney and testicle), gastrointestinal (anus, rectum, stomach, colon, liver and pancreas), central nervous system (brain and spinal cord) and hematolymphoid malignancies. He is an assistant professor in the Department of Radiation Oncology at University of Maryland School of Medicine.
Dr. Molitoris has given many national and international presentations on his work. He has received awards for his presentations from the American Radium Society and International Congress for Hyperthermic Oncology.
In addition, Dr. Molitoris has previously been named a "Top Doctor" in the radiation oncology field by Baltimore magazine.
Board Certification and Education
Medical School:
Case Western Reserve University School of Medicine, 2013
Internship:
Greater Baltimore Medical Center, 2014
Residency:
University of Maryland Medical Center, 2018
Certification:
American Board of Radiology - Radiation Oncology, 2019
Hospital Affiliations
UM Shore Regional Health - Dorchester/Easton
UM Upper Chesapeake Health
UM Baltimore Washington Medical Center
University of Maryland Medical Center
Research and Publications
Dr. Molitoris is an active clinician and researcher in the Department of Radiation Oncology at University of Maryland School of Medicine. His research focuses on the implementation of advanced treatment technologies to his clinical areas of interest and evaluating newer approaches to improve treatment effectiveness while decreasing side effects.
Dr. Molitoris has multiple peer-reviewed publications from both his basic science and clinical research. His medical school dissertation focused on the abnormal regulation of cell death in leukemia and lymphoma. While a resident at University of Maryland Medical Center, he maintained his interest in basic science by applying his knowledge to novel mechanisms of radiosensitization. He also became interested in clinical trial development. He attended the American Association for Cancer Research and American Society of Clinical Oncology (AACR/ASCO) clinical trials workshop in Vail, Colorado, during his final year of residency.
In addition, Dr. Molitoris is a Radiological Society of North America Roentgen Resident/Fellow Research Award recipient.
Ratings and Reviews
The star rating is an average of responses to our patient satisfaction survey. Patients measure their experience with our providers on a scale of 1 to 5 stars, 1 being “Very Poor” and 5 being “Very Good.” Learn more about the patient satisfaction survey.
Dr. Molitoris is great. He takes however much time is necessary to make sure I clearly understand every aspect of my condition and the options going forward. His recommendations are well considered and I am completely comfortable with his approach to treatment.
